✦ LIBER ✦

Accounting for disease modifying therapy in models of clinical progression in multiple sclerosis

✍ Scribed by Brian C. Healy; David Engler; Taha Gholipour; Howard Weiner; Rohit Bakshi; Tanuja Chitnis

Book ID: 119303979
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 138 KB
Volume: 303
Category: Article
ISSN: 0022-510X
DOI: 10.1016/j.jns.2010.12.024

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Disease modifying therapies in multiple

Disease modifying therapies in multiple sclerosis

✍ B. Sharrack; T. Jenkins 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB

Emerging Disease-Modifying Therapies in

Emerging Disease-Modifying Therapies in Multiple Sclerosis

✍ Perumal, Jai; Khan, Omar 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 150 KB

Adherence to Disease-Modifying Therapy i

Adherence to Disease-Modifying Therapy in Multiple Sclerosis: Part I

✍ Nancy Holland; Phyllis Wiesel; Pamela Cavallo; Clayton Edwards; June Halper; Ros 📂 Article 📅 2001 🏛 Association of Rehabilitation Nurses 🌐 English ⚖ 587 KB

Adherence to Disease-Modifying Therapy i

Adherence to Disease-Modifying Therapy in Multiple Sclerosis: Part II

✍ Nancy Holland; Phyllis Wiesel; Pamela Cavallo; Clayton Edwards; June Halper; Ros 📂 Article 📅 2001 🏛 Association of Rehabilitation Nurses 🌐 English ⚖ 647 KB

Cost-Effectiveness of Disease-Modifying

Cost-Effectiveness of Disease-Modifying Therapies in Multiple Sclerosis

✍ Manouchehrinia, Ali; Constantinescu, Cris S. 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 186 KB

Current and future disease-modifying the

Current and future disease-modifying therapies in multiple sclerosis

✍ S. Y. Lim; C. S. Constantinescu 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 250 KB